T
Tomas R. Vazquez-Rodriguez
Researcher at University of Cantabria
Publications - 62
Citations - 2831
Tomas R. Vazquez-Rodriguez is an academic researcher from University of Cantabria. The author has contributed to research in topics: Giant cell arteritis & Rheumatoid arthritis. The author has an hindex of 24, co-authored 61 publications receiving 2571 citations.
Papers
More filters
Journal ArticleDOI
Epidemiology of giant cell arteritis and polymyalgia rheumatica.
Miguel A. Gonzalez-Gay,Tomas R. Vazquez-Rodriguez,Maria J. Lopez-Diaz,José A. Miranda-Filloy,Carlos González-Juanatey,Javier Martin,Javier Llorca +6 more
TL;DR: Giant cell arteritis and Polymyalgia rheumatica are relatively common diseases in the elderly due to the progressive aging of the population in Western countries.
Journal ArticleDOI
Strokes at Time of Disease Diagnosis in a Series of 287 Patients With Biopsy-Proven Giant Cell Arteritis
Miguel A. González-Gay,Tomas R. Vazquez-Rodriguez,Inés Gómez-Acebo,Robustiano Pego-Reigosa,Maria J. Lopez-Diaz,Matilde C. Vazquez-Triñanes,José A. Miranda-Filloy,Ricardo Blanco,Trinidad Dierssen,Carlos González-Juanatey,Javier Llorca +10 more
TL;DR: Results of the current study show an increased risk of strokes, in the vertebrobasilar territory in particular, at the time of GCA diagnosis and suggest a potential protective role of anemia against the development of these cerebrovascular complications.
Journal ArticleDOI
The high prevalence of subclinical atherosclerosis in patients with ankylosing spondylitis without clinically evident cardiovascular disease.
Carlos González-Juanatey,Tomas R. Vazquez-Rodriguez,José A. Miranda-Filloy,Trinidad Dierssen,Ines Vaqueiro,Ricardo Blanco,Javier Martín,Javier Llorca,Miguel A. González-Gay +8 more
TL;DR: Results of the present study show that patients with ankylosing spondylitis without clinically evident cardiovascular disease have a high prevalence of subclinical macrovascular disease in the form of increased carotid IMT andCarotid plaques compared to matched controls.
Journal ArticleDOI
Insulin resistance in rheumatoid arthritis: the impact of the anti-TNF-α therapy
Miguel A. González-Gay,Carlos González-Juanatey,Tomas R. Vazquez-Rodriguez,José A. Miranda-Filloy,Javier Llorca +4 more
TL;DR: A dramatic improvement of insulin resistance and insulin sensitivity was observed and a long‐term positive effect of TNF‐α antagonists infliximab and etanercept on insulin resistance in RA patients with severe disease was reported.
Journal ArticleDOI
TNFA -308 (rs1800629) polymorphism is associated with a higher risk of cardiovascular disease in patients with rheumatoid arthritis.
Luis Rodriguez-Rodriguez,Luis Rodriguez-Rodriguez,Carlos González-Juanatey,Rogelio Palomino-Morales,Tomas R. Vazquez-Rodriguez,José A. Miranda-Filloy,Benjamín Fernández-Gutiérrez,Javier Llorca,Javier Martín,Miguel A. González-Gay +9 more
TL;DR: The results show that TNFA rs1800629 gene polymorphism is associated with predisposition to CV complications in patients with RA, and this predisposition is restricted to individuals carrying the rheumatoid SE.